mbiomics, a Bavaria-based BioTech startup advancing scalable microbiome-based therapeutics for severe and chronic diseases, has announced the third closing of…
Read More
Stockholm’s BioLamina secures €20 million EIB loan to scale cell therapies for chronic diseases
BioLamina, a Stockholm-based BioTech scale-up specialising in matrix biology and cell culture, has secured a €20 million financing commitment from…
Read More
NanoZymeX secures €160K to advance lipid nanoparticle enzyme therapies for rare diseases
Biotech startup NanoZymeX has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new platform for enzyme replacement therapy…
Read More
Excruciating tropical disease can now be transmitted in most of Europe, study finds | Infectious diseases
An excruciatingly painful tropical disease called chikungunya can now be transmitted by mosquitoes across most of Europe, a study has…
Read More
Rome-based VoiceMed reaches €1 million in total funding; launches pilot for early detection of chronic respiratory diseases
VoiceMed, a Rome-based digital health company developing voice-based solutions for remote monitoring of chronic respiratory issues, today announced that it…
Read More
Milan Mishkovikj: Ongoing Pandemic of Liver Diseases in Europe
Milan Mishkovikj, Vice-President, Program Manager, and Volunteer at Hepar Centar Bitola, and Board Director at ELPA, shared some insights on…
Read More
CARPHA, EU unveil mobile lab to fight mosquito-borne diseases
CARPHA Launches EU-Funded Mobile Insectary Facility to Strengthen Vector Control and Outbreak Readiness Across the Region The Caribbean Public Health…
Read More
Phagos obtains €25M boost to combat bacterial diseases
Paris-based Phagos has closed a €25 million Series A funding round, four years after its founding. The round was co-led…
Read More
RFK unveils plan to tackle childhood chronic diseases, points to Europe
Washington, DC – The United States Health and Human Services Secretary Robert F. Kennedy Jr has unveiled a national strategy…
Read More
Danish BioTech scale-up SNIPR Biome raises €35 million to tarobtain antimicrobial resistance in diseases like cancer
Copenhagen-based SNIPR Biome, a BioTech company innovating the development of microbial CRISPR-medicine, announced the close of a €35 million Series…
Read More
